The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)

Lung cancer is the leading cause of cancer-related mortality worldwide, with non-small cell lung cancer (NSCLC) accounting for over 85% of all cases. Until recently, chemotherapy – characterized by some benefit but only rare durable responses – was the only treatment option for patients with NSCLC w...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunother Cancer
Main Authors: Brahmer, Julie R., Govindan, Ramaswamy, Anders, Robert A., Antonia, Scott J., Sagorsky, Sarah, Davies, Marianne J., Dubinett, Steven M., Ferris, Andrea, Gandhi, Leena, Garon, Edward B., Hellmann, Matthew D., Hirsch, Fred R., Malik, Shakuntala, Neal, Joel W., Papadimitrakopoulou, Vassiliki A., Rimm, David L., Schwartz, Lawrence H., Sepesi, Boris, Yeap, Beow Yong, Rizvi, Naiyer A., Herbst, Roy S.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Position Article and Guidelines
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6048854/
https://ncbi.nlm.nih.gov/pubmed/30012210
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-018-0382-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados